Clinical Trials
- Infectious Disease
Immune signatures of vaccine responses in vulnerable populations: Comparison of influenza vaccines
- Ages21 years and older
- GenderBoth
Randomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPEC9V in the Prevention ofInv asive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years And Older with a History of Urinary Tract Infection in the Past 2 Years VAC52416BAC3001
- Ages60 years and older
- GenderBoth
- Immune System
Characterization of Immune Response to Intradermal Flu Vaccination
- Ages18 years - 40 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
Evaluating the Immune Response to COVID-19 Vaccination in B-cell Depleted Patients
- Ages18 years and older
- GenderBoth
- Infectious Disease, COVID-19 Vaccine
The TIPI Study
- Ages18 years - 65 years
- GenderBoth